Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeremy Shefner, MD, PhD
State University of New York - Upstate Medical University
Study ChairKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California at San Francisco, Fresno Campus, Central California Neurological Institute
Fresno, California, United States
- Coordinated Clinical Research
La Jolla, California, United States
- University of California at Irvine, Als and Neuromuscular Center
Orange, California, United States
- Hospital for Special Care
New Britain, Connecticut, United States
- Massachusetts General Hospital, Neurology Clinical Trials Unit
Charlestown, Massachusetts, United States
- Washington University
St Louis, Missouri, United States
- Cornell Faculty, Hospital for Special Surgery
New York, New York, United States
- Duke University School of Medicine, Division of Neurology
Durham, North Carolina, United States
- Ohio State University, Department of Neurology
Columbus, Ohio, United States
- Providence Als Center
Portland, Oregon, United States
- University of Texas Health Science Center, Department of Neurology
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2011
- Primary completion
- 31 Mar 2012
- Completion
- 31 Mar 2012
- Last update posted
- 3 May 2019
- Registered enrollment
- 27
- Registry id
- NCT01486849
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.